Log In
BCIQ
Print this Print this
 

Ziagen, abacavir

Also known as: 1592 (formerly 1592U89)

  Manage Alerts
Collapse Summary General Information
Company GlaxoSmithKline plc
DescriptionNucleoside analog reverse transcriptase inhibitor (NRTI)
Molecular Target Viral polymerase
Mechanism of ActionViral polymerase inhibitor
Therapeutic ModalitySmall molecule
Latest Stage of DevelopmentMarketed
Standard IndicationHIV / AIDS
Indication DetailsTreat HIV infection; Treat HIV infection/AIDS; Treat HIV-1 infection
Regulatory Designation
PartnerPfizer Inc.

 Product Details
 Archive Items are loading loading
Collapse Summary Deals Information
Total Number of DealsTotal Deal ValueTotal Upfront CashTotal Milestone Payments

1

0

0

0


 Deals Details
DateCompanies InvolvedDeal HeadlineTotal Deal ValueTotal Upfront CashTotal Milestone

07/20/2009

Undisclosed

Undisclosed

Undisclosed

Get a free BioCentury trial today